title: Comment on: "Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis".
authors.forename: Fanpu
authors.initials: F
authors.lastname: Ji
authors.forename: Zhifang
authors.initials: Z
authors.lastname: Cai
authors.forename: Hong
authors.initials: H
authors.lastname: Deng
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008113:Liver Neoplasms / Q000517:prevention & control*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons